MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

Search

Evolent Health Inc

Abrir

SetorSaúde

4.18 5.56

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.06

Máximo

4.25

Indicadores-chave

By Trading Economics

Rendimento

30M

-21M

Vendas

35M

480M

Margem de lucro

-4.351

Funcionários

4,500

EBITDA

512K

15M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+142.17% upside

Dividendos

By Dow Jones

Próximos Ganhos

19 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-321M

458M

Abertura anterior

-1.38

Fecho anterior

4.18

Sentimento de Notícias

By Acuity

34%

66%

106 / 372 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bullish Evidence

Evolent Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de jan. de 2026, 23:11 UTC

Ganhos

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 de jan. de 2026, 22:55 UTC

Grandes Movimentos do Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 de jan. de 2026, 21:39 UTC

Grandes Movimentos do Mercado

Raytheon Down Following Trump Post Criticizing Company

7 de jan. de 2026, 20:13 UTC

Grandes Movimentos do Mercado

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 de jan. de 2026, 20:03 UTC

Grandes Movimentos do Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 de jan. de 2026, 23:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 de jan. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 de jan. de 2026, 23:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 de jan. de 2026, 22:48 UTC

Conversa de Mercado

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 de jan. de 2026, 22:46 UTC

Ganhos

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 de jan. de 2026, 22:45 UTC

Ganhos

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 de jan. de 2026, 22:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 de jan. de 2026, 22:42 UTC

Ganhos

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 de jan. de 2026, 22:41 UTC

Ganhos

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 de jan. de 2026, 22:41 UTC

Ganhos

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 de jan. de 2026, 22:40 UTC

Grandes Movimentos do Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 de jan. de 2026, 22:31 UTC

Conversa de Mercado

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 de jan. de 2026, 22:22 UTC

Conversa de Mercado

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 de jan. de 2026, 22:01 UTC

Conversa de Mercado

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

7 de jan. de 2026, 21:46 UTC

Conversa de Mercado

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 de jan. de 2026, 21:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 de jan. de 2026, 21:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 de jan. de 2026, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 de jan. de 2026, 20:29 UTC

Aquisições, Fusões, Aquisições de Empresas

AbbVie Near Deal for Revolution Medicines -- Update

7 de jan. de 2026, 20:27 UTC

Conversa de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 de jan. de 2026, 19:58 UTC

Conversa de Mercado

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 de jan. de 2026, 19:48 UTC

Grandes Movimentos do Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Comparação entre Pares

Variação de preço

Evolent Health Inc Previsão

Preço-alvo

By TipRanks

142.17% parte superior

Previsão para 12 meses

Média 10.05 USD  142.17%

Máximo 16 USD

Mínimo 7 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Evolent Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

13 ratings

13

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

10.33 / 10.95Suporte e Resistência

Curto Prazo

Very Strong Bullish Evidence

Médio Prazo

Very Strong Bullish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

106 / 372 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat